Avoiding prophylactic tracheostomies in head and neck surgeries with reconstructive free flaps: An institutional shift in practice

BACKGROUND: In 2018, an initiative at the authors' institution aimed at reducing routine prophylactic tracheostomies for head and neck reconstructions with free flaps was implemented. Discussion between the surgical team and anesthesia about if a tracheostomy should be performed became the standard of care. The safety of this selective approach is assessed. METHODS: Retrospective review of patients ≥18-years who underwent a free flap for oral or oropharyngeal primaries from 2015 to 2021 at a single centre. Statistical analysis included subgroup analysis of patients pre-vs. post-2018. RESULTS: A total of 411 patients were included. Prophylactic tracheostomy rates decreased from 92.6% to 42.7% pre-2018 to post-2018. There was no significant difference in airway compromise or flap failure rates with non-tracheostomy. Post-2018, variables associated with tracheostomies included oropharynx primaries, advanced clinical nodal disease, and bilateral neck dissection (p < 0.05). On multivariate regression, surgical time (OR 1.182, p < 0.001), anesthetic time (OR 1.165, p < 0.001) and advanced clinical nodes (OR 1.304, p < 0.05) had increased odds of tracheostomy post-2018, while scapula vs. radial forearm free flaps had decreased odds (OR 0.717, p < 0.05). Patients with tracheostomies had longer hospital stays and more observed post-operative complications (p < 0.05). CONCLUSION: Prophylactic tracheostomies can be safely avoided in select patients undergoing oral and oropharyngeal free flaps, with no difference in airway or flap failure complications. These findings support multidisciplinary discussion between surgical and anesthetic teams regarding the indications for tracheostomies in head and neck cases. Further prospective studies are needed to identify exact criteria for tracheostomies in head and neck reconstructions with free flaps.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

More peer-reviewed studies in Klinische Studien.

• Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
• Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• HIRUDOTHERAPY IN PRESBYACUZIS PRAECOX IN CLEAN-UP WORKERS AFTER THE CHORNOBYL ACCIDENT DURING THE POST-CATASTROPHE YEARS — Zabolotnyi D, Mishchanchuk N (2019)
• Wound healing potential of bark paste of Pongamia pinnata along with hirudotherapy: A case report — Balasooriya D, Karunarathna C, Uluwaduge I (2021)
• AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech — Baranzini N et al. (2019)
• Study on the effect of medicinal leech therapy (Hirudo medicinalis) on full-thickness excisional wound healing in the animal model — Zakian A et al. (2022)
• [Hirudo medicinalis-leech applications in plastic and reconstructive microsurgery--a literature review] — Knobloch K et al. (2007)
• The duration of rest and feeding greatly affects the re-breeding of ectoparasites: Hirudo verbana, Hirudo medicinalis and Hirudo orientalis — Aminov R, Frolov A, Aminova A (2022)
• Recombinant hirudin in clinical practice: focus on lepirudin — Greinacher A, Lubenow N (2001)

Browse all ASH-analysed research →